Functional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Three genes encoding for mitochondrial complex II proteins are linked to hereditary paraganglioma. We have recently shown that an inactivation of the SDHD gene is associated with a complete loss of mitochondrial complex II activity and a stimulation of the angiogenic pathway (Gimenez-Roqueplo, A. P., J. Favier, P. Rustin, J. J. Mourad, P. F. Plouin, P. Corvol, A. Rötig, and X. Jeunemaitre, 2001, Am J Hum Genet 69:1186-1197). Here, we relate the case of a malignant sporadic pheochromocytoma induced by a germline missense mutation of the SDHB gene. Within the tumor, a loss of heterozygosity at chromosome 1pter led to a null SDHB allele and to a complete loss of complex II enzymatic activity. In situ hybridization and immunohistochemistry experiments showed a high expression of hypoxic-angiogenic responsive genes, similar to that previously observed in inherited-SDHD tumors. This observation highlights the role of the complex II mitochondrial genes in the oxygen-sensing pathway and in the regulation of angiogenesis of neural crest-derived tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondrial complex II is a component of the electron transport chain, and mutations of SDHB or SDHD genes that abrogate the oxidoreductase function of complex II can cause pheochromocytomas [9,14,15].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [14]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“The SDHD and SDHC genes were sequenced as previously described (1, 3).”
MethodGerm-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Cellular oxygen sensing by mitochondria: old questions, new insight
Chandel, N. S., & Schumacker, P. T. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.5.1880 · Cited by 391
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364 · cited 6×
“The expression of five genes (EPAS1, VEGF, VEGFR-1, VEGFR-2, and neuron-specific enolase) encoding angiogenic and hypoxia-induced factors was studied in SDHB-mutated pheochromocytoma tissue by immunohistochemistry and in situ hybridization with procedures previously described (5, 9).”
BackgroundMethodSelf-citationSuccinate dehydrogenase and fumarate reductase from Escherichia coli
Cecchini, G., Schröder, I., Gunsalus, R. P., & Maklashina, E. (2002) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00238-9 · Cited by 283 · cited 4×
“00/0 The Journal of Clinical Endocrinology & Metabolism 87(10):4771–4774”
BackgroundInfluentialGimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Germline SDHD mutation in familial phaeochromocytoma
Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G. R., Eng, C., Latif, F., & Maher, E. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04378-6 · Cited by 246 · cited 1×
“catecholamine-secreting pheochromocytomas (5, 6), heredi-”
Enhancement of mRNA in situ hybridization signal by microwave heating.
Sibony, M., Commo, F., Callard, P., & Gasc, J. (1995) · PubMed · Cited by 135
Cited by
Items 201–217 of 217
Carney-Stratakis Syndrome Caused by a Novel SDHD Mutation
Chng, C. L., Sheikh, S. E., Caplin, M. E., Baker, D., & Khoo, B. C. E. (2015) · AACE Clinical Case Reports · doi:10.4158/ep14331.cr
Rogers, K., & Lenoir, G. (2014) · International Journal of Cancer · doi:10.1002/ijc.29131
“Somatic LOH associated with inactivating germline mutations in SDHB and loss of SDH activity has been implicated in the activation of hypoxic responses and malignant transformation.(24) The reviews featured in this Special Section offer an exciting perspective on emerging research in the areas of RA signaling, neurobl…”
Phénotype métabolique des tumeurs associées à des anomalies du cycle de Krebs
Janin, M. (2015) · theses.fr (ABES) · doi:10.70675/c12cbd69zd09fz4fddz91dbz86f7655d32c8
Chiaw Ling Chng, MB BS, MRCP, FAMS 1 ; Soha El Sheikh, MBChB, FRCPath, PhD 2 ;
Caplin, M. E., Baker, D., & Khoo, B. C. E. (2015)
Lussey‐Lepoutre, C. (2015) · theses.fr (ABES) · doi:10.70675/024d7dfdz0a77z4938z961aza39e67b5ea2a
Metabolic rewiring in response to genetic and environmental preturbations in cancer
Hollinshead, K. E. R. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
Identification de nouveaux gènes de prédisposition aux parangangliomes
Buffet, A. (2018) · theses.fr (ABES) · doi:10.70675/919a7ecez1b81z4189z937fz709f94a68c6d
Neuropeptide cocaine- and amphetamine-regulated transcript usage in Parkinson's disease
Mao, P., & Mao, Y. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815946-0.00039-9
Paraganglioma and Pheochromocytoma
Sandberg, A. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_5
(2007) · Wiley eBooks · doi:10.1002/9780470692196.refs
Zibari, G. B., Sanders, M., & Shokouh-Amiri, H. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1423-4_14
Goncalves, J. (2021) · theses.fr (ABES) · doi:10.70675/c8c1e120z2ec7z4009zb20bz9588f2985a48
Impériale, A. (2014) · theses.fr (ABES) · doi:10.70675/f8e51b70zbc26z42f5z91fcz3e1b3a3e8c91 · Cited by 1
Impact des mutations SDH sur la réponse antitumorale et identification de nouveaux biomarqueurs
Lamy, C. (2021) · theses.fr (ABES) · doi:10.70675/036f6787z50daz43e6zbeafzbcebfb700048
Drossart, T. (2025) · theses.fr (ABES) · doi:10.70675/3d7ac8c8z01e3z43b5z8286ze5ede0f2dec4
Metadata
- Authors
- Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Rieubland, C., Kerlan, V., Plouin, P.-F., Rötig, A., & Jeunemaitre, X.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-10
- Volume
- 87
- Issue
- 10
- Pages
- 4771-4774
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2144878030
- Cited by
- 209
- References
- 13
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 14 · 2014: 15 · 2013: 13 · 2012: 15
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Keywords
- sporadic pheochromocytoma, succinate dehydrogenase, loss of heterozygosity, hypoxia-inducible factor, angiogenesis, oxygen sensing, neural crest-derived tumors, hereditary paraganglioma, germline missense mutation, tumor suppressor
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Adrenal Gland Neoplasms, Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Iron-Sulfur Proteins, Lymphokines, Middle Aged, Multienzyme Complexes, Mutation, Oxidoreductases, Pheochromocytoma, RNA, Messenger, Succinate Dehydrogenase, Tomography, X-Ray Computed, Trans-Activators, Gene Expression, Endothelial Growth Factors, In Situ Hybridization, Sequence Analysis, DNA, Germ-Line Mutation, Loss of Heterozygosity, Mutation, Missense, Protein Subunits, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Electron Transport Complex II, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.